Interlinkage among cardio-metabolic disease markers in an urban poor setting in Nairobi, Kenya

Tilahun Nigatu Haregu1, Samuel Oti2,3,4, Nicholas Ngomi2

  • 1African Population and Health Research Center, Nairobi, Kenya; tharegu@aphrc.org.

Global Health Action
|February 12, 2016
PubMed

Insights

Cardio-metabolic markers like blood pressure and glucose are interconnected in sub-Saharan Africa. This suggests a higher risk of multiple conditions, highlighting the need for integrated health strategies.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Public Health in Africa

Background:

  • Cardio-metabolic diseases share common markers such as elevated blood pressure and glucose.
  • Interlinkage of these markers suggests a higher likelihood of co-occurrence.
  • Limited data exists on cardio-metabolic marker patterns in sub-Saharan Africa.

Purpose of the Study:

  • To investigate the interlinkage among common cardio-metabolic disease markers.
  • To provide insights into cardio-metabolic health in an African urban slum setting.

Main Methods:

  • Cross-sectional study of 5,190 participants in Nairobi, Kenya.
  • Analysis of waist circumference, blood pressure, random blood glucose, total blood cholesterol, and triglyceride levels.
  • Statistical analysis using means, standard deviations, proportions, and odds ratios.

Main Results:

  • Prevalence: central obesity (12.3%), hypertension (7.0%), hyperglycemia (2.5%), hypercholesterolemia (10.3%), hypertriglyceridemia (17.3%).
  • Women showed higher central obesity and hypercholesterolemia.
  • Blood glucose strongly associated with central obesity, blood pressure, and triglycerides.

Conclusions:

  • Common cardio-metabolic markers are significantly interlinked.
  • Findings indicate a higher probability of cardio-metabolic comorbidity.
  • The study underscores the necessity for integrated healthcare approaches for managing these conditions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
737
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
711
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K